uz
Feedback
Respiratory Updates

Respiratory Updates

Kanalga Telegram’da o‘tish

🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Ko'proq ko'rsatish

📈 Telegram kanali Respiratory Updates analitikasi

Respiratory Updates (@respiratoryupdates) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 19 410 obunachidan iborat bo'lib, Tibbiyot toifasida 1 179-o'rinni va Eron mintaqasida 17 286-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 19 410 obunachiga ega bo‘ldi.

26 Avgust, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 460 ga, so‘nggi 24 soatda esa 14 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 22.08% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 5.52% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 4 284 marta ko‘riladi; birinchi sutkada odatda 1 070 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 3 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent patient, guideline, edit, reader, society kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Yuqori yangilanish chastotasi (oxirgi ma’lumot 27 Avgust, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

19 410
Obunachilar
+1424 soatlar
+1117 kunlar
+46030 kunlar
Postlar arxiv
+1
🔴 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement

IDSA_Treatment_of_Antimicrobial_Resistant_Gram_Negative_Infections.pdf1.15 MB

Repost from Pulmonology pearls
SARCOIDOSIS: Edited by Vasileios Kouranos and Maneesh Bhargava Recent updates in advanced pulmonary sarcoidosis Current Opinion in Pulmonary Medicine 32(5):p 491-499, September 2026. | DOI: 10.1097/MCP.0000000000001295

Repost from Pulmonology pearls
Respiratory Medicine Volume 255, April–May 2026, 108751 Original Research The effect of the CareAide® mobile application in adult outpatients with asthma: A randomised controlled trial https://doi.org/10.1016/j.rmed.2026.108751

Repost from Pulmonology pearls
Navigating evidence-based recommendations for the management of systemic sclerosis. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01416-z

Repost from Pulmonology pearls
Review Article Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials the Nebulized Heparin Study Group Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161

Annals of intensive care.pdf1.02 MB

Repost from Pulmonology pearls
American Journal of Kidney Diseases Available online 3 July 2026 In Press, Journal Pre-proof Perspective Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies https://doi.org/10.1053/j.ajkd.2026.03.048

ICU Nutrition Q&A.pdf5.85 KB

Repost from N/a
خلاصه وازوپرسو و اینوتروپ #Critical_Care
خلاصه وازوپرسو و اینوتروپ #Critical_Care

Repost from N/a
آقای ۶۲ ساله با تشخیص شوک سپتیک ناشی از پنومونی، در icu . بیمار تحت رژیم درمانی با نوراپی‌نفرین ۳۶ میکروگرم در دقیقه قرار دارد. در آخرین بررسی: · MAP = ۵۵ U/O = ۰.۳ cc/kh/ht · لاکتات سرم = ۴.۲ (روند نزولی ندارد) · CRT = ۴ بهترین اقدام؟
Anonymous voting

Repost from Pulmonology pearls
Feature Article Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis Critical Care Medicine 54(6):p 1293-1308, June 2026. | DOI: 10.1097/CCM.0000000000007072

Repost from Pulmonology pearls
+2
The Lancet Respiratory Medicine Available online 5 June 2026 In Press, Corrected Proof Position Paper Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement https://doi.org/10.1016/S2213-2600(26)00094-9

Critical_Care_2025 مبادرة خير.pdf18.04 MB

Repost from Yasser ICU
photo content
+1

Repost from Yasser ICU
photo content
+1

Repost from Yasser ICU
The new ACC/AHA 2026 guidelines of pulmonary embolism

Repost from Pulmonology pearls
creager_et_al_2026_2026_aha_acc_accp_acep_chest_sc_260219_225656.pdf15.12 MB

photo content

Repost from Pulmonology pearls
The Lancet Respiratory Medicine Available online 12 February 2026 In Press, Corrected Proof Articles Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials KALOS and LOGOS study investigators † https://doi.org/10.1016/S2213-2600(25)00457-6